@windhamvp

FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma

ST. HELIER, Jersey–(BUSINESS WIRE)– NovoTTF-100L, a Tumor Treating Fields delivery system, is the first FDA-approved mesothelioma treatment in more than 15 years In the STELLAR trial, malignant pleural mesothelioma patients … Continued

MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System

LEXINGTON, Mass. and NORTH CHICAGO, Ill. –  (BUSINESS WIRE) MC10, Inc., a healthcare technology company specializing in wearable digital health sensors, and AbbVie(NYSE: ABBV), a research-based global biopharmaceutical company, announced today that the … Continued